Uroporphyrinogen decarboxylase: optimizing radiotherapy for head and neck cancer

Future Oncol. 2011 May;7(5):595-7. doi: 10.2217/fon.11.27.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Cetuximab
  • Head and Neck Neoplasms / enzymology*
  • Head and Neck Neoplasms / radiotherapy*
  • Humans
  • Porphyrins / therapeutic use
  • Radiation, Ionizing
  • Radiation-Sensitizing Agents / therapeutic use*
  • Survival Rate
  • Tirapazamine
  • Triazines / therapeutic use
  • Uroporphyrinogen Decarboxylase / metabolism*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Porphyrins
  • Radiation-Sensitizing Agents
  • Triazines
  • texaphyrin
  • Tirapazamine
  • Uroporphyrinogen Decarboxylase
  • Cetuximab